CompoAtlas

新樂康芝麻膠囊食品

新樂康芝麻膠囊食品 : Product registered in Taiwan. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

TFDA, Taiwan tablets, capsules and medical nutrition registers, retrieved 27 October 2026.

Taiwan Food and Drug Administration (TFDA), Open Government Data License, version 1.0

Open Government Data License, version 1.0

The foreign register category does not determine the regulatory category of the product in France.

French and European references for recognised ingredients

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Published ingredientPublished text and quantityIdentified nutrient or substance
ROYAL JELLYROYAL JELLYGelée royale
SESAME SEED EXTRACTSESAME SEED EXTRACTNot identified
TOMATO POWDERTOMATO POWDERNot identified
BEE POLLENBEE POLLENNot identified
GREEN TEAGREEN TEANot identified
GRAPE SEED POWDER EXTRACTGRAPE SEED POWDER EXTRACTNot identified
APPLE PECTINAPPLE PECTINPectine de pomme
ALFALFAALFALFANot identified
ACAI BERRYACAI BERRYNot identified
SELENIUM YEASTSELENIUM YEASTSélénium
SOY BEAN OILSOY BEAN OILNot identified
GELATINGELATINNot identified
GLYCEROLGLYCEROLGlycérol
PURIFIED WATERPURIFIED WATERNot identified
MAGNESIUM STEARATEMAGNESIUM STEARATENot identified
TITANIUM DIOXIDETITANIUM DIOXIDENot identified
CARAMEL COLORS (PLAIN CARAMEL)CARAMEL COLORS (PLAIN CARAMEL)Not identified

The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.

Product record

Registration number
1086608003
Chinese name
新樂康芝麻膠囊食品
English name
SHINROKAN SESAME CAPSULES
Type
Imported tablets and capsules
Published status
Status not provided in this export; the validity date is shown separately
Licence holder
德效國際有限公司
Registration date
2019-09-04
Published validity end
2029-09-04

Original register data

View published fields and their variants
Product name
新樂康芝麻膠囊食品
Active ingredients
ROYAL JELLY;;SESAME SEED EXTRACT;;TOMATO POWDER;;BEE POLLEN;;GREEN TEA;;GRAPE SEED POWDER EXTRACT;;APPLE PECTIN;;ALFALFA;;ACAI BERRY;;SELENIUM YEAST;;SOY BEAN OIL;;GELATIN;;GLYCEROL;;PURIFIED WATER;;MAGNESIUM STEARATE;;TITANIUM DIOXIDE;;CARAMEL COLORS (PLAIN CARAMEL);;
Valid until
1180904
Registration number
1086608003
Licence holder
德效國際有限公司
Registration date
1080904
Published reference
DHC0A866080033
Published English name
SHINROKAN SESAME CAPSULES

Official source

View the official register, number 1086608003

Taiwan Food and Drug Administration (TFDA), Open Government Data License, version 1.0

Open Government Data License, version 1.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • ROYAL JELLY
    Read the warning, when it applies and the studies cited

    ROYAL JELLY

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Contraindications

    Do not use if you have a history of asthma or allergies (TGA 2001; Leung et al. 1997; Harwood et al. 1996; Laporte et al. 1996; Thien et al. 1996; Leung et al. 1995; Peacock et al. 1995; Bullock 1994).

    Sources cited by Health Canada (8)
    • Bullock RJ. Fatal royal-jelly induced asthma. Medical Journal of Australia 1994;160:44. PubMed Case report
    • Harwood M, Harding S, Beasley R, Frankish PD. Asthma following royal jelly. The New Zealand Medical Journal 1996;109:325. PubMed Case report
    • Laporte JR, Ibaanez L, Vendrell L, Ballarin E. Bronchospasm induced by royal jelly. Allergy 1996;51:440. PubMed
    • Leung R, Ho A, Chan J, Choy D, Lai CK. Royal jelly consumption and hypersensitivity in the community. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 1997;27(3):333-336. PubMed
    • Leung R, Thien FC, Baldo B. Royal Jelly-induced asthma and anaphylaxis: clinical characteristics and immunologic correlations. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 1995;96:1004-1007. PubMed Case report
    • Peacock S, Muray V, Turton C. Respiratory distress and royal jelly. British Medical Journal 1995;311:1472. PubMed Case report
    • TGA 2001: Australian Therapeutic Goods Administration. CMEC 28: Complementary Medicines Evaluation Committee, Extracted Ratified Minutes twenty-eight Meeting, 27-28 July 2001. Australian Government Department of Health and Aging, Sydney, Australia; 2001. [Accessed 2025 February 5]. Available from: https://www.tga.gov.au/sites/default/files/cmec-minutes-28.pdf
    • Thien FC, Leung R, Baldo BA, Weiner JA, Plomley R, Czarny D. Asthma and anaphylaxis induced by royal jelly. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 1996;26(2):216-222. PubMed

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (Leung et al. 1997; Laporte et al. 1996; Thien et al. 1996; Leung et al. 1995; Peacock et al. 1995).

    Sources cited by Health Canada (6)
    • Laporte JR, Ibaanez L, Vendrell L, Ballarin E. Bronchospasm induced by royal jelly. Allergy 1996;51:440. PubMed
    • Leung R, Ho A, Chan J, Choy D, Lai CK. Royal jelly consumption and hypersensitivity in the community. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 1997;27(3):333-336. PubMed
    • Leung R, Thien FC, Baldo B. Royal Jelly-induced asthma and anaphylaxis: clinical characteristics and immunologic correlations. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 1995;96:1004-1007. PubMed Case report
    • Peacock S, Muray V, Turton C. Respiratory distress and royal jelly. British Medical Journal 1995;311:1472. PubMed Case report
    • Thien FC, Leung R, Baldo BA, Weiner JA, Plomley R, Czarny D. Asthma and anaphylaxis induced by royal jelly. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 1996;26(2):216-222. PubMed
    • Harwood M, Harding S, Beasley R, Frankish PD. Asthma following royal jelly. The New Zealand Medical Journal 1996;109:325. PubMed Case report

    Health Canada monograph dated 24 April 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “新樂康芝麻膠囊食品”, https://compoatlas.com/en/supplements/taiwan/1086608003-shinrokan-sesame-capsules, updated 27 October 2026.

Enter to analyse, Shift+Enter for a new line